Riot Blockchain Inc  

(Public, NASDAQ:RIOT)   Watch this stock  
Find more results for NASDAQ:BIOP
+0.78 (10.39%)
Mar 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 7.30 - 8.45
52 week 3.06 - 46.20
Open 7.31
Vol / Avg. 1.20M/2.13M
Mkt cap 80.08M
P/E     -
Div/yield 1.00
EPS -1.92
Shares 9.66M
Beta 2.69
Inst. own 18%

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -22055.42% -45359.23%
Operating margin -2442.10% -66954.67%
EBITD margin - -58734.61%
Return on average assets -141.40% -22.55%
Return on average equity -197.33% -27.57%
Employees 7 -
CDP Score - -


202 6th St Ste 401
CASTLE ROCK, CO 80104-1724
United States - Map
+1-303-7942000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Riot Blockchain Inc., formerly Bioptix, Inc., intends to gain exposure to the block chain ecosystem through targeted investments in the sector, with a primary focus on the bitcoin and Ethereum blockchains. The Company also provides Enhanced Surface Plasmon Resonance (SPR) platform for the detection of molecular interactions. The Company's line of Enhanced SPR instruments are designed to increase the flexibility and reliability of SPR. Its SPR biosensors shed light on important binding parameters that are crucial for determining whether a biologic or small molecule drug efficacious in humans and at what dose a drug should be administered. Its technology is an ultra-sensitive detection platform. The design of its SPR spectrometers allows discrete areas within the sample cell to be interrogated simultaneously. Its biosensors provide information on kinetic processes, binding affinities, analyte concentrations and real-time molecule detection.

Officers and directors

John O'Rourke Chairman of the Board, Chief Executive Officer
Age: 32
Bio & Compensation  - Reuters
Robby Chang Chief Financial Officer, Principal Accounting Officer
Bio & Compensation  - Reuters
Christopher Ensey Chief Operating Officer
Bio & Compensation  - Reuters
Edward Lee Director of Business Development
Bio & Compensation  - Reuters
Jeffrey G. McGonegal Corporate Secretary
Age: 66
Bio & Compensation  - Reuters
Andrew E. Kaplan Independent Director
Age: 50
Bio & Compensation  - Reuters
Remo Mancini Independent Director
Age: 66
Bio & Compensation  - Reuters
Eric How-Lun So Independent Director
Age: 42
Bio & Compensation  - Reuters